Stocks · News reference
Corteva, Inc. reported its third-quarter 2026 financial results, showing a decline in net sales and adjusted operating EBITDA, and updated its full-year 2026 guidance due to weaker market conditions in Brazil.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Vylor headlines Wednesday’s reports as investors assess how the newly covered consumer-staples company will be received, while Franco-Nevada offers a read on precious-metals exposure after a strong stock run. CGI, ICL
Clearwater Paper, Sasol and Corteva are deeply oversold by RSI, potentially offering undervalued buying opportunities.
Wisner Baum LLP has filed a lawsuit in Los Angeles County Superior Court alleging that Corteva and The Dow Chemical Company are responsible for Parkinson's disease cases linked to their chlorpyrifos products.
Corteva, Inc. has announced a reduction in its quarterly dividend from $0.18 to $0.05 per share, payable on December 15, 2026.
Corteva Agriscience representative Subroto Geed has been appointed to the Board of Directors of CropLife Asia, the regional plant science industry association.